Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of H. Pylori Eradication with Tegoprazan in Functional Dyspepsia
NCT05786807Phase 4Unknown
- Sponsor
- Wonkwang University Hospital
- Start
- Mar 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegoprazan in functional dyspepsia (FD), Helicobacter pylori infection, sponsored by Wonkwang University Hospital. Status: unknown.
02
Drugs
tegoprazan
03
Conditions
functional dyspepsia (FD)Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05786807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05786807.